Triptans for migraine

David William Dodick, Hans Christoph Diener

Research output: Book/ReportBook

Abstract

The triptans have provided desperately needed acute relief from migraine attacks for millions of patients around the world and have ushered in a new era of scientific discovery in the molecular biology and receptor pharmacology of migraine headache. It is two decades since sumatriptan was designed and approved for the acute treatment of migraine, and there are now seven triptans available, in multiple formulations. This book of seven chapters, from some of the world's most experienced and expert clinicians and clinician-scientists, contains the latest information on the pathophysiology of migraine headache and the current understanding on the mechanism of action of triptans. It provides an overview of the clinical efficacy of oral triptans and the multiple existing and emerging formulations available for use in those for whom oral medications are not suitable. Safety and tolerability issues are also addressed, together with the use of triptans in special populations such as children, the elderly and pregnant women. The book closes with a summary of treatment recommendations and consensus guidelines.

Original languageEnglish (US)
PublisherFuture Medicine Ltd.
Number of pages96
ISBN (Print)9781780840666, 9781780841335
DOIs
StatePublished - Jan 1 2012

Fingerprint

Tryptamines
Migraine Disorders
Sumatriptan
Pregnant Women
Molecular Biology
Pharmacology
Guidelines
Safety
Therapeutics
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dodick, D. W., & Diener, H. C. (2012). Triptans for migraine. Future Medicine Ltd. https://doi.org/10.2217/9781780840666

Triptans for migraine. / Dodick, David William; Diener, Hans Christoph.

Future Medicine Ltd., 2012. 96 p.

Research output: Book/ReportBook

Dodick DW, Diener HC. Triptans for migraine. Future Medicine Ltd., 2012. 96 p. https://doi.org/10.2217/9781780840666
Dodick, David William ; Diener, Hans Christoph. / Triptans for migraine. Future Medicine Ltd., 2012. 96 p.
@book{7f55868d2f024bbe9a299bd85486f998,
title = "Triptans for migraine",
abstract = "The triptans have provided desperately needed acute relief from migraine attacks for millions of patients around the world and have ushered in a new era of scientific discovery in the molecular biology and receptor pharmacology of migraine headache. It is two decades since sumatriptan was designed and approved for the acute treatment of migraine, and there are now seven triptans available, in multiple formulations. This book of seven chapters, from some of the world's most experienced and expert clinicians and clinician-scientists, contains the latest information on the pathophysiology of migraine headache and the current understanding on the mechanism of action of triptans. It provides an overview of the clinical efficacy of oral triptans and the multiple existing and emerging formulations available for use in those for whom oral medications are not suitable. Safety and tolerability issues are also addressed, together with the use of triptans in special populations such as children, the elderly and pregnant women. The book closes with a summary of treatment recommendations and consensus guidelines.",
author = "Dodick, {David William} and Diener, {Hans Christoph}",
year = "2012",
month = "1",
day = "1",
doi = "10.2217/9781780840666",
language = "English (US)",
isbn = "9781780840666",
publisher = "Future Medicine Ltd.",

}

TY - BOOK

T1 - Triptans for migraine

AU - Dodick, David William

AU - Diener, Hans Christoph

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The triptans have provided desperately needed acute relief from migraine attacks for millions of patients around the world and have ushered in a new era of scientific discovery in the molecular biology and receptor pharmacology of migraine headache. It is two decades since sumatriptan was designed and approved for the acute treatment of migraine, and there are now seven triptans available, in multiple formulations. This book of seven chapters, from some of the world's most experienced and expert clinicians and clinician-scientists, contains the latest information on the pathophysiology of migraine headache and the current understanding on the mechanism of action of triptans. It provides an overview of the clinical efficacy of oral triptans and the multiple existing and emerging formulations available for use in those for whom oral medications are not suitable. Safety and tolerability issues are also addressed, together with the use of triptans in special populations such as children, the elderly and pregnant women. The book closes with a summary of treatment recommendations and consensus guidelines.

AB - The triptans have provided desperately needed acute relief from migraine attacks for millions of patients around the world and have ushered in a new era of scientific discovery in the molecular biology and receptor pharmacology of migraine headache. It is two decades since sumatriptan was designed and approved for the acute treatment of migraine, and there are now seven triptans available, in multiple formulations. This book of seven chapters, from some of the world's most experienced and expert clinicians and clinician-scientists, contains the latest information on the pathophysiology of migraine headache and the current understanding on the mechanism of action of triptans. It provides an overview of the clinical efficacy of oral triptans and the multiple existing and emerging formulations available for use in those for whom oral medications are not suitable. Safety and tolerability issues are also addressed, together with the use of triptans in special populations such as children, the elderly and pregnant women. The book closes with a summary of treatment recommendations and consensus guidelines.

UR - http://www.scopus.com/inward/record.url?scp=84959124197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959124197&partnerID=8YFLogxK

U2 - 10.2217/9781780840666

DO - 10.2217/9781780840666

M3 - Book

AN - SCOPUS:84959124197

SN - 9781780840666

SN - 9781780841335

BT - Triptans for migraine

PB - Future Medicine Ltd.

ER -